539561 — Remedium Lifecare Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Remedium Lifecare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	900	5,048	5,098	40,417	4,053
Cost of Revenue
Gross Profit	22.9	63.2	160	403	71.2
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	894	5,032	5,025	40,085	4,064
Operating Profit	6.53	16.3	73.2	332	-11.3
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6.53	15.3	74	505	43.8
Provision for Income Taxes
Net Income After Taxes	4.8	10.8	54.3	327	21.3
Net Income Before Extraordinary Items
Net Income	4.8	10.8	54.3	327	21.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4.8	10.8	54.3	327	21.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.008	0.019	0.094	0.567	0.035